Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
613,145
-
Share change
-
+320,869
-
Total reported value
-
$568,449
-
Price per share
-
$0.93
-
Number of holders
-
11
-
Value change
-
+$294,571
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of Estrella Immunopharma, Inc. - COM (ESLA) as of Q1 2025
As of 31 Mar 2025,
Estrella Immunopharma, Inc. - COM (ESLA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
613,145 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, UBS Group AG, ATW SPAC MANAGEMENT LLC, BlackRock, Inc., STATE STREET CORP, MASO CAPITAL PARTNERS Ltd, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.